Serial Number
90287671
Owner
Invizyne Technologies, Inc.Attorney
Thomas C. Lundin Jr.First Use Date
May 25, 2023
Filing Date
Oct 29, 2020
INVIZYNE Trademark
Serial Number: 90287671
Trademark Classes
Class 3 - Cosmetics & Cleaning
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Class 4 - Lubricants & Fuels
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 30 - Staple Foods
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Owner Contact Info
Legal Representation
Correspondence Address
Thomas C. Lundin Jr. FisherBroyles LLP
111 Favre St
Waveland, MS 39576
UNITED STATES
Trademark Details
Filing Date
October 29, 2020
Registration Date
Not Registered
First Use Anywhere
May 25, 2023
First Use in Commerce
May 25, 2023
Published for Opposition
January 4, 2022
Goods & Services
Flavor enhancers for use in food and beverage products
Pharmaceuticals, namely, alcohols, esters, alkaloids, polyketides, steroids, isoprenoids, and non-ribosomal peptides, for use the treatment of pain, neuropathic pain, cancer pain, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, multiple sclerosis, spinal cord injury, bladder disfunction, peripheral neuropathy, spasticity, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, post-traumatic stress disorder, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse, epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome, chromosome disorders, and metabolic disorders; anti-inflammatories; analgesics; nutraceuticals for use as a dietary supplement; dietary and nutritional supplements; none of the foregoing containing CBD, cannabinoids or tryptamines
Biofuels; fuels, biofuels and biodiesels based on energy-producing organic compounds, namely, terpenes, isoprenoids, alcohols, fatty acids, esters, alkanes, and alkenes
Fragrances; terpenes for use in essential oils
